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Abstract
Background: Immunoglobulin G4-related disease (IgG4-RD) is a multiorgan fibroinflammatory condition with
lymphoplasmacytic infiltrates containing abundant IgG4-positive plasma cells. The immunopathogenesis of the
disease and the potential role of triggering autoantigens or infectious factors have not been clearly defined.
Immunoglobulin G4-related lung disease is a new and emerging condition in pediatric patients and to date, there
have been only two reports regarding pulmonary manifestation of IgG4-RD in children recently published. This is
the first report of IgG4-related lung disease in an immunodeficient child with Epstein-Barr virus infection.
Case presentation: We report on the case of a 7-year old atopic boy who was hospitalized with an initial clinical
and radiological diagnosis of pneumonia, positive Epstein-Barr virus (EBV)-DNA in the blood and defective adaptive
immunity. The lung CT showed a consolidated mass lesion adjacent to the posterior wall of the chest and the
diaphragm. The child underwent surgical resection of the tumor, and the histologic examination of the lung specimens
revealed lymphoplasmacytic infiltrates with fibrosis and vasculitis correlating with IgG4-related lung disease. Subsequent
monitoring of the patient with lung CT, pulmonary function tests and IgG4 levels did not show signs of active disease.
Conclusions: The diagnosis of IgG4-related lung disease in children is challenging because of its rarity, nonspecific
symptomatology and heterogeneous morphological manifestations. Further studies are required in children with
pulmonary presentation of IgG4-RD to better understand pathogenesis of this condition, possible immunological or
infectious triggering factors, and finally, to determine pediatric patient-targeted therapeutic interventions.
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Background
Immunoglobulin G4-related disease (IgG4-RD) is a sys-
temic fibroinflammatory condition with elevated serum
IgG4 concentration in most cases and multiorgan involve-
ment. It is characterized by lymphoplasmacytic infiltrates
with fibrosis, phlebitis and an accumulation of IgG4-
expressing plasma cells at the affected sites. IgG4-related
disease is an emerging and increasingly recognized condi-
tion with a broad spectrum of clinicopathologic features
and various clinical phenotypes, including manifestations
in the digestive system, the exocrine and endocrine glands,
kidneys, soft tissues, the skin, the cardiovascular system
and the respiratory tract [1, 2]. The immunopathogenesis
of the disease, the potential role of triggering autoantigens
or infectious factors and the defective innate or adaptive
immune response have not been clearly defined [3]. The
demography of IgG4-RD was initially characteristically
limited to adult patients, with 90 % of them being
aged >50 years and with pancreatitis as a leading
manifestation [4], but synchronous or metachronous
development of fibroinflammatory lesions in other organs
led to the concept of systemic IgG4-RD. Lesions associated
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with IgG4-RD can also be localized in the respiratory
tract, in the lung parenchyma, airways, pleura, and in
the mediastinum [5, 6]. IgG4-RD is an unrecognized
disease and to date, there have been only two reports
regarding IgG4-related lung disease in children which
have been recently published [7, 8]. To our knowledge,
this is the first report of a pediatric patient with IgG4-
related lung disease coexisting with defective T-cell and
B-cell-related adaptive immunity and EBV infection.
Case presentation
We report on the case of a 7-year-old boy referred to
our pediatric pneumonology, allergology and clinical im-
munology department because of chest pain and fever.
He had the history of a blunt injury to the right side of
his chest while he was training in martial arts a few days
before admission. He did not manifest either cough, dys-
pnea, problems with breathing or hemoptysis nor had
night sweats, weight loss or chronic loss of appetite.
His past medical history was significant for allergic
rhinitis and a few episodes of bronchitis which have
been treated with inhaled bronchodilators (see Add-
itional file 1). The family history was non-contributory.
On admission the patient was febrile with body
temperature 38,6 °C, anxious, with respiratory distress,
tachypnea, shallow respiration, dyspnea, and intercostal
retractions. The physical examination revealed subman-
dibular and cervical lymphadenopathy, purulent secretions
on the erythematous posterior pharyngeal wall, chronic
tonsillitis, and on lung auscultation, diminished breath
sounds over the right lower lobe at the back and at the
front axillary line, starting from the fifth intercostal space.
The chest X-ray (CXR) showed a round lesion in the right
lower lobe consistent with parenchymal infiltrations (Fig. 1)
and hypoechogenic areas in the lung ultrasound examin-
ation. Assuming this to be pneumonia, the patient was ad-
ministered combined intravenous antibiotic therapy with
cefotaxime and clarithromycin, but despite improvement in
his general condition, the consolidation in the right lung
did not resolve. A chest computed tomography (CT) was
then conducted and revealed a solid, well-defined mass in
the right lower lobe with calcifications, surrounded by
ground-glass haze and contiguous to the posterior chest
wall, the diaphragm and the lung hilum (Figs. 2 and 3). In-
ferring this to be a neoplastic lesion the VATS (video-
Fig. 1 CXR showing a round lesion in the right lower lobe consistent
with alveolar infiltrations, localized in segments 7, 8, and 9 and
7,0 × 5,0 cm in size (length x width) with air bronchogram
Fig. 2 Chest CT (axial view) showing a well-defined solid mass in
the right lower lobe with calcifications, surrounded by ground-glass
haze and contiguous to the posterior chest wall, the diaphragm and
the lung hilum
Fig. 3 Chest 3D CT scan, volume rendering technique (VRT),
evaluating the tumor mass
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assisted thoracoscopy) lung biopsy was performed which
showed an inflammatory pseudotumor. A broad differential
diagnosis was performed, including laboratory tests (sum-
marized in Table 1). Since the results of the lung biopsy
were inconclusive, the tumor was surgically removed and a
histologic examination of the lung specimens was carried
out, showing features of IgG4-RD. Microscopic analysis
of the lung specimens revealed a focal lesion with cen-
tral sclerosing, infiltrating alveolar septa, surrounding
bronchovascular bundles and vascular walls. In the
areas of the massive storiform fibrosis, disseminated
abundant lymphoplasmacytic infiltrations with sparse
eosinophils, obliterating vascular lumen were observable.
Detailed description of the histopathologic findingss, in-
cluding microscopic analysis and immunohistochemical
(IHC) reactions, is displayed in Table 2. As IgG4-RD is
potentially a relapsing condition, close monitoring of
the disease activity is of utmost importance. At present,
after a six-month post-surgery period, the lung CT shows
only a limited fibrotic strand. IgG4 serum levels, both
pre and postoperative, remain normal (42,16 mg/dl vs
42,59 mg/dl, respectively). During follow-up visits the
child remains symptom-free and without further treat-
ment. A PET (positron emission tomography) scan has
been considered for the next follow-up visit to exclude
a systemic manifestation of IgG4-RD and eventually to
give implications for immunosuppressive therapy.




White blood count 10,61 G/l, lymphocytic predominance in differential (57 %)
C-reactive protein (CRP) increased 2,46 mg/dl
Biochemistry Serum activity of amylase 23 IU/l, lipase 3 IU/l, aminotransferases normal
Infections Specific serum IgM and IgG antibodies against Mycoplasma pneumoniae, Toxoplasma gondii, hepatitis B and C viruses
(HBV, HCV), cytomegalovirus (CMV) negative
Epstein-Barr virus (EBV)-DNA in blood positive (1400 copies/ml)
Galactomannan (Aspergillus antigen) in serum negative
QuantiFERON TB negative
Sputum culture: Staphylococcus aureus MSSA
Neoplastic markers Serum alpha-fetoprotein (AFP) 1,1 ng/ml, carcinoembryonic antigen (CEA) 0,24 ng/ml, beta-human chorionic gonadotropin
(β-HCG) <2,39 mIU/ml not elevated
Secretion of catecholamines in 24-hour urine collection normal: vanillylmandelic acid (VMA) 7,3 mg/24 hrs,
dopamine 190,6 mcg/24 hrs
Allergy Total serum IgE elevated 660 kU/l
Allergen-specific IgE against airborn and food allergens: horse 0,7 kU/l (1 class), wormwood 0,7 kU/l (1 class)
Immunology Serum immunoglobulin (Ig) G and M normal (989 and 86 mg/dl, respectively), IgA increased 197 mg/dl
Complement in serum normal C3 135 mg/dl, C4 23 mg/dl
IgG subclasses normal: IgG1 617,90 mg/dl, IgG2 237,20 mg/dl, IgG3 54,87 mg/dl, IgG4 42,16 mg/dl
Flow cytometric peripheral blood immunophenotyping: lymphocytes 5300 cells (50 %), increased absolute count
and relative value of CD8+ T cells (2760 cells/mm3, 50 %) and decreased of CD4+ T cells (718 cells/mm3, 13 %),
defective B-cell maturation: decrease of the absolute count and relative value of switched memory CD19 + CD27 + sIgD- B cells
(39 cells/mm3, 7,9 %) and of non-switched memory CD19 + CD27 + sIgD+ B cells (14 cells/mm3, 2,9 %),
plasmablasts CD19 + CD38hisIgM- normal (13 cells/mm3, 2,6 %)
Autoimmunization ANA antibodies against nRNP/Sm, Sm, SS-A, SS-B, Ro-52, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, AMA M2, dsDNA, nucleosomes,
histones, ribosomal protein P negative
ANCA antibodies against protease-3, myeloperoxidase, elastase, lactoferrin, catepsin G, BPI negative
Table 2 Histopathologic features of the lung biopsy
Histopathology Features
Microscopic analysis Marked CD138+ plasma cells and lymphocytes
Infiltrations by IgG4-positive plasma cells with
IgG4:IgG >40 %
IgG4 cells per HPF >10
Storiform fibrosis
Obliterative vascular lesions (EvG staining)












Other stainings Trichrom-Masson (+)
Amyloid (−)
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Conclusions
Immunoglobulin G4-related lung disease manifests with
a spectrum of nonspecific symptoms such as cough, dys-
pnea, fever, and hemoptysis which along with pulmonary
consolidations may mimic pneumonia or pleural effusion
[5, 6, 9]. In children, the rarity of IgG4-RD is the next
challenge in establishing an accurate diagnosis [7, 8] and
the disease remains unrecognized. However, the aware-
ness of IgG4-RD among pediatricians is increasing and
more and more case reports on affected children with
broad clinical presentation and histologically proven, are
available [10]. In the child studied, histopathologic
examination including microscopic analysis with immu-
nohistochemical reactions revealed lymphoplasmacytic
infiltrates, storiform fibrosis, obliterative vascular lesions
as well as IgG4:IgG ratio ≥40 % and IgG4-positive plasma
cell numbers per HPF (high-power field) ≥10, meeting the
criteria according to the Consensus Statement on Path-
ology of IgG4-RD [11]. Despite well-defined histological
features of IgG4-RD in different unrelated organs, import-
ant questions need to be addressed about the exact role of
IgG4, which is in general an antiinflammatory isotype
[12, 13], in the immunopathology of this condition, the
potential self or non-self antigens driving the immune re-
sponse and the importance of atopy and hyperimmuno-
globulinemia E [14, 15]. In our patient we performed a
broad multidirectional differential diagnostic tests evaluat-
ing the immune response, allergy, autoimmunization and
infections, showing positive Epstein-Barr virus (EBV)-
DNA and abnormalities in adaptive immune response
such as increased values of CD8+ T lymph cells and
decreased values of CD4+ T lymph cells accompanied by
features of defective B lymph cell maturation, with de-
creased formation in the switched and non-switched
memory cells. EBV is an ubiquitous virus in humans and
can remain latent throughout life, but in immunocom-
promised children it can reactivate and a correlation
between EBV-DNA load in peripheral blood and severity
of clinical manifestations was observed [16]. However,
whether there is a causal relationship between an EBV
infection as the source of a potential target antigen for
IgG4 antibodies and defective collaboration between B
and T lymph cells, histopathological features with plasma-
blast expansion remains to be elucidated [17]. Further-
more, clinicopathological correlations between
morphological solid nodular, bronchovascular or alveolar
interstitial types of pulmonary lesions and potential infec-
tious, autoimmune, allergic and toxic factors remain to be
determined [18–20]. Further studies are required in chil-
dren with pulmonary presentation of IgG4-RD to better
understand pathogenesis of this condition, possible
immunological or infectious triggering factors, and finally,
to determine pediatric patient-targeted therapeutic
interventions.
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